Total planned funding: $464,494,220
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $89,719,799 |
Mozambique | $68,156,995 |
South Africa | $57,222,650 |
Asia Regional Program | $39,203,137 |
Kenya | $32,373,815 |
Burundi | $17,270,688 |
Zambia | $16,372,197 |
Zimbabwe | $14,613,585 |
Vietnam | $14,079,195 |
West Africa Region | $13,460,980 |
Dominican Republic | $9,170,526 |
Democratic Republic of the Congo | $9,080,260 |
Papua New Guinea | $7,203,865 |
Botswana | $6,876,354 |
Ethiopia | $6,548,504 |
Malawi | $6,512,359 |
enumerations.Philippines | $6,341,584 |
Côte d'Ivoire | $5,832,349 |
Tanzania | $5,822,881 |
Indonesia | $5,494,394 |
Uganda | $5,479,539 |
Angola | $4,472,878 |
India | $4,410,871 |
Lesotho | $3,642,229 |
Eswatini | $3,355,402 |
Caribbean Region | $2,519,565 |
Central America Region | $2,283,457 |
South Sudan | $2,274,062 |
Rwanda | $1,713,822 |
Haiti | $1,117,260 |
Western Hemisphere Region | $709,018 |
Namibia | $450,000 |
Cameroon | $360,000 |
Central Asia Region | $350,000 |
Ghana | $0 |
Organizational Types
NGO | $464,494,220 |
Program Areas
Treatment | $141,225,287 |
Care | $132,362,061 |
Prevention | $91,229,243 |
Testing | $60,767,539 |
Governance and Systems | $38,910,090 |
Budget Codes
HTXS: Treatment: Adult Treatment | $130,423,951 |
HKID: Care: Orphans and Vulnerable Children | $65,718,671 |
HVCT: Testing: HIV Testing and Counseling | $60,767,539 |
HBHC: Care: Adult Care and Support | $51,144,078 |
HVOP: Sexual Prevention: Other Sexual Prevention | $46,848,650 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $17,900,153 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,345,130 |
HVSI: Strategic Information | $15,057,708 |
OHSS: Health Systems Strengthening | $13,868,202 |
HLAB: Laboratory Infrastructure | $9,984,180 |
HVTB: Care: TB/HIV | $8,947,945 |
PDCS: Care: Pediatric Care and Support | $6,551,367 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,772,624 |
PDTX: Treatment: Pediatric Treatment | $5,719,222 |
HTXD: Treatment: ARV Drugs | $5,082,114 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,745,494 |
HMIN: Biomedical Prevention: Injection Safety | $438,760 |
HMBL: Biomedical Prevention: Blood Safety | $178,432 |
Top Partner Programs
FHI 360:
$464,494,220
View countries